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Background: Saliva plays a major role in preserving the integrity of oral tissues. The oral health of renal failure 
patients could be negatively affected by the underlying pathology, the dialysis treatment, or an altered salivary 
composition. Major systemic changes occur during hemodialysis (HD), which could affect the flow rate and bio-
chemical composition of saliva. Therefore, the aim of this study was to evaluate the effects of HD on the salivary 
flow rate, pH and biochemical composition before and after completion of a dialysis session.
Material and Methods: Thirty Renal failure patients undergoing hemodialysis were selected based on the inclu-
sion and exclusion criteria set forth for the study. Unstimulated whole saliva (UWS) was collected by the spitting 
method, immediately before and after a dialysis session. Salivary flow rate, pH, concentration of urea, creatinine, 
sodium, chloride, potassium and calcium were measured.
Results: Hemodialysis had an acute stimulating effect on the salivary flow rate. The mean pH of UWS showed 
no significant changes before and after dialysis. The concentrations of urea, creatinine, chloride and potassium in 
whole saliva changed markedly before and after a hemodialysis session; whereas no significant difference was seen 
in the concentration of sodium and calcium.
Conclusions: This study shows that HD has significant acute effects on both salivary secretion and biochemical 
composition in saliva. We conclude that the observed changes in salivary concentrations and flow rate are mainly 
due to an increased watery secretion from the salivary glands and also saliva can be used as a tool for monitoring 
hemodialysis.
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Introduction
Saliva is the body’s mirror. The ability to use saliva to 
monitor the health and disease state of an individual is 
a highly desirable goal for health promotion and health 
care research. Molecular diagnostics contributes into a 
wide range of disciplines including drug development, 
personalized medicine (pharmacogenomics) and plays a 
major role in discovery of biomarkers for the diagnosis 
of oral and systemic diseases. In the present study we 
focus on the use of salivary biomarkers for the diagnosis 
of End Stage Renal Disease (ESRD) and also for deter-
mining the effectiveness of hemodialysis.
Over the last decades, the prevalence and incidence of 
ESRD has increased. The incidence increases with age 
and male individuals are more commonly affected than 
females. The most common causes of ESRD are chronic 
hypertension, glomerulonephritis, polycystic kidney di-
sease, renovascular disease and diabetes mellitus (1,2).
Patients with ESRD can rely on kidney replacement 
therapeutic modalities such as hemodialysis (HD), pe-
ritoneal dialysis (PD) or renal transplantation. Although 
kidney replacement therapies have proven to be suc-
cessful in prolonging the life expectancy of ESRD pa-
tients, several limitations and long-term complications 
exist (3). Dialysis leads to systemic alterations, oral 
complications and variations in the flow and composi-
tion of saliva. Salivary function including lubrication, 
buffering action, maintenance of tooth integrity, antibac-
terial activity, taste and digestion may be disturbed by 
salivary flow and biochemical alterations (4). In ESRD 
patients, the oral health could also negatively be affected 
by the underlying pathology, the dialysis treatment, oral 
dryness or an altered salivary composition (5,6).
Measurement of biological markers that demonstrate 
identifiable and regular changes from pre dialysis to post 
dialysis states can enable necessary monitoring of dialy-
sis efficacy and the level of renal function in patients 
with end stage renal disease. The present study was un-
dertaken to analyze the flow rate, pH and biochemical 
composition (urea, creatinine, sodium, chloride, potas-
sium, calcium) of saliva in patients with renal failure un-
dergoing hemodialysis. This study helps us to determine 
the salivary biomarkers to monitor dialysis efficacy and 
also to understand the effects of hemodialysis on sali-
vary composition, function and the relationship between 
oral and salivary changes in renal insufficiency. 
Material and Methods
The present study was carried out by the Department of 
Oral Medicine and Radiology, Farooqia Dental College 
and Hospital, Mysuru to determine the effect of hemo-
dialysis on the flow rate, pH and biochemical composi-
tion of saliva (urea, creatinine, sodium, chloride, potas-
sium, calcium) in chronic renal failure patients before 
and after a hemodialysis session. 
Ethical clearance was obtained from the institutional 
ethical committee to perform this study.
The study sample comprised of thirty subjects with 
ESRD, who were selected from the outpatients under-
going hemodialysis in the Department of General Me-
dicine, Krishna Rajendra Hospital, Mysuru by simple 
random sampling based on the following inclusion and 
exclusion criteria.
Inclusion criteria:
Patients of either sex in the age group of 18 – 80 years, 
with End stage renal disease having a glomerular filtra-
tion rate of < 15 ml/min, undergoing hemodialysis were 
included in the study.
Exclusion criteria:
Patients with any of the following features were not in-
cluded in the study:
•Diseases affecting water and electrolyte balance like 
Diabetes Insipidus, Thyroid disorders except Diabetes 
Mellitus.
•Patients under medication (other than insulin and anti-
hypertensives) that could affect saliva production.
•Patients with salivary gland disorders.
Patients were explained about the procedure and after ob-
taining the informed consent unstimulated whole saliva 
was collected by the spitting method. Saliva was collected 
immediately before a dialysis session (before) and directly 
after completion of the dialysis session (after). 
For estimation of salivary flow rate, all subjects were 
instructed to refrain from eating and drinking for one 
hour prior to the saliva collection. In each patient, the 
samples were collected during one dialysis session. 
The collection started with the instruction to void the 
mouth of saliva by swallowing. Subsequently, saliva 
was allowed to accumulate in the floor of the mouth and 
the subjects were instructed to spit out into the sterile 
calibrated container every 30 seconds. Each saliva co-
llection period was five minutes and following sample 
collection the flow rate (ml/min) was calculated.  
After saliva collection, pH was measured using the pH 
indicator strip (Merck). One drop of the collected saliva 
sample was placed on the test strip and its color change 
indicated the pH of saliva.
The samples were stored in an ice box at -20 degree Cel-
sius and sent to laboratory within 30 minutes of sample 
collection.  The saliva samples were then centrifuged at 
4000 rpm for 10 minutes, to eliminate cellular debris. 
Then the concentration of salivary urea, creatinine, so-
dium, chloride, potassium and calcium were determined 
using auto analyzer. 
The results were subjected to statistical analysis using 
Descriptive statistics, Chi-square test, Paired sample‘t’ 
test and Contingency coefficient analysis. The statistical 
analysis was done using the SPSS version 16 statistical 
software package. Data were collected, tabulated and 
then subjected to the statistical analysis. The qualitative 
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data were presented as numbers and percentages and the 
Chi square test was used to examine the significance of 
the differences in mean and distribution of categorical 
variables between groups. The data were presented as 
mean ± standard deviation and the paired sample t-test 




To compare the salivary flow rate before and after hemo-
dialysis paired samples statistics was applied. The mean 
flow rate before was 0.46 ± 0.27 mL/min and mean flow 
rate after hemodialysis was 0.84 ± 0.34mL/min. There 
was a statistically significant difference between the sa-
livary flow rate before and after hemodialysis, as P value 
of 0.000 was obtained.
Salivary pH:
The mean pH before hemodialysis was 6.39 ±1.1 and 
mean pH after was 6.54 ± 0.60. There was no statistica-
lly significant difference between the salivary pH before 
and after hemodialysis, as the P value was 0.239.
Saliva composition:
Biochemical parameters measured in saliva are shown 
in Table 1.
The salivary composition of Chronic Kidney Disease 
(CKD) patients differed before and after a dialysis ses-
sion. Concentrations of urea, creatinine, potassium and 
chloride were found to be significantly lower in patients 
after hemodialysis than it was before hemodialysis. The-
re were no statistically significant changes seen in the 
Parameters Before Dialysis After Dialysis
Mean Flow Rate 0.4600 0.8433
Mean pH 6.3967 6.5467
Mean Urea 161.5000 99.2667
Mean Creatinine 1.4433 1.0133
Mean Sodium 12.5667 13.6967
Mean Chloride 37.8000 27.3833
Mean Potassium 27.4457 22.6073
Mean Calcium 8.7767 8.7600
Table 1: Shows the mean concentration of the salivary flow rate in ml/min, pH and 
biochemical constituents Urea in mg/dl, Creatinine in mg/dl, Sodium in mmol/L, 
Chloride in mmol/L, Potassium in mmol/L, Calcium in mg/dl, before and after he-
modialysis.
concentrations of sodium and calcium, before and after 
hemodialysis.
The mean concentration of urea before hemodialysis 
was 161.50 ± 90.21 mg/dl and mean urea concentration 
after was 99.26 ± 62.87 mg/dl, with a P value of 0.000 
which is statistically significant. The mean concentration 
of creatinine before was 1.4 ± 0.6 mg/dl and mean crea-
tinine concentration after was 1.01 ± 0.56 mg/dl, which 
was also statistically significant.
The mean sodium concentration before hemodialysis 
was 12.56 ± 8.07 mmol/L and mean sodium concentra-
tion after was 13.69 ± 6.95 mmol/L; The mean calcium 
concentration before hemodialysis was 8.77 ± 0.53 mg/
dl and mean calcium concentration after was 8.76 ± 0.52 
mg/dl which was not significant statistically with a P va-
lue of 0.114 and 0.876 respectively (Table 2).
The mean concentration of chloride before hemodialy-
sis was 37.80 ± 13.63 mmol/L and mean chloride con-
centration after was 27.38 ± 11.85 mmol/L; The mean 
potassium concentration before hemodialysis was 27.44 
± 9.51 mmol/L and mean potassium concentration after 
was 22.60 ± 7.58 mmol/L which was statistically sig-
nificant with a P value of 0.000 and 0.002 respectively 
(Table 2), (Figs. 1-4).
Discussion 
The ability to monitor health status, disease onset, pro-
gression, and treatment outcome through non-invasive 
means is a highly desirable goal in health care promo-
tion and delivery. Saliva is a perfect medium to be ex-
plored for health and disease surveillance. The advan-
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Table 2: Shows the Paired Samples t-test of difference in salivary constituents before and after hemodialysis. 
Paired Differences t df Sig. (2-tailed)
Mean
Flow Before – After -0.38333 -10.872 29 0.000
pH Before – After -0.15000 -1.203 29 0.239
Urea Before – After 62.23333 9.986 29 0.000
Creatinine Before – After 0.43000 6.609 29 0.000
Sodium Before – After -1.13000 -1.629 29 0 .114
Chloride Before – After 10.41667 7.406 29 0.000
Potassium Before – After 4.83833 3.412 29 0.002
Calcium Before – After 0.01667 0.158 29 0.876
(df – Degree of freedom, Sig. – Significance).
tages of saliva as a clinical tool over serum and tissues 
are a noninvasive collection of sample, smaller sample 
fractions, good patient cooperation, cost effectiveness, 
easy storage and transportation, repeated sampling for 
monitoring over time, greater sensitivity, and correlation 
with levels in blood.
Chronic renal failure (CRF) is characterized by progres-
sive loss of kidney function. Patients with CRF usually 
have some oral manifestations of the disease, and one 
way to improve quality of life is to promote oral health. 
Oral manifestations generally observed in patients with 
Fig. 1: Graph showing the mean Salivary flow rate in ml/min and pH 
before and after hemodialysis.
Fig. 2: Graph showing the mean concentration of Salivary Urea be-
fore and after hemodialysis in mg/dl.
CRF include enamel hypoplasia, pallor of the oral mu-
cosa, xerostomia, uremic odor, low caries prevalence in 
both primary and permanent dentitions, as well as a lar-
ge amount of calculus (6).
Although kidney replacement therapies have proven to 
be successful in prolonging the life expectancy of ESRD 
patients, several limitations and long-term complications 
exist (7). Dialysis leads to systemic alterations, oral com-
plications and variations in the flow and composition of 
saliva. Salivary functions including lubrication, buffe-
ring action, maintenance of tooth integrity, antibacterial 
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Fig. 3: Graph showing the mean concentrations of Salivary Creati-
nine and Calcium before and after hemodialysis in mg/dl.
Fig. 4: Graph showing the mean concentrations of Salivary Sodium, 
Chloride and Potassium before and after hemodialysis in mmol/L.
activity, and taste and digestion may by disturbed by al-
tered salivary flow and composition (4). It is considered 
that determination of some biomarkers in saliva can be 
effective alternative method for monitoring the efficacy 
of the treatment with dialysis in CKD patients.
Our study evaluated the salivary secretion of patients 
with chronic renal failure by evaluating whole saliva, 
which is a mixed oral fluid formed by secretion of the 
major and minor salivary glands. Although in the who-
le saliva there are components of non-salivary origin, 
whole saliva is a good source of salivary components 
for evaluation. 
Salivary Flow rate and pH:
In our study, assessment of the salivary flow rate before 
and after a dialysis session (Before - 0.4 +/- 0.2ml/min 
and after - 0.8 +/- 0.3 ml/min) was found to be statisti-
cally significant (P < 0.005). No major differences in 
salivary pH were found in the study sample, before and 
after a dialysis session. This result is consistent with the 
previous study by Martins et al. (8) who also found sta-
tistically significant difference between the salivary flow 
rate before and after a hemodialysis session, and also 
between patients on hemodialysis and healthy controls. 
Similar results were obtained by Kaushik et al. (9) who 
found statistically significant lower stimulated and uns-
timulated salivary flow rate in patients on dialysis when 
compared to healthy controls.
Bayraktar et al. (10) reported the stimulated salivary 
flow rate to be significantly lower in patients on hemo-
dialysis when compared to patients on peritoneal dialy-
sis and healthy controls. They also found a statistically 
significant higher salivary pH and buffer capacity in pa-
tients on peritoneal and hemodialysis when compared 
to controls. In a study by Al Nowaiser et al. (11) there 
was no significant difference in saliva flow rate in the 
CRF children compared with the controls. The buffering 
capacity and pH was significantly greater in the CRF 
group when compared with the controls.
Biochemical composition of Saliva:
Normal blood urea concentration is 30-40 mg/dl where as 
the normal urea of saliva is 12-70 mg/dl. The normal range 
of serum creatinine is 0.6 – 1.5mg/dL and salivary creati-
nine is 0.05–0.2 mg/dL. In the present study, we found a 
statistically significant difference in the concentrations of 
salivary urea, creatinine, potassium and chloride.
This result is consistent with the results obtained by See-
thalakshmi et al. (12) who did a Correlation of Serum 
and Salivary Biochemical Parameters in end Stage Re-
nal Disease Patients Undergoing Hemodialysis in Pre 
and Post-Dialysis State. They found a statistically signi-
ficant difference between blood and salivary urea, crea-
tinine, potassium and phosphate levels before and after 
a hemodialysis session. Whereas no statistically signifi-
cant difference was found in blood and salivary sodium 
levels before and after a hemodialysis session
Serum and salivary creatinine levels were significantly 
higher in CKD patients than controls, in the study done 
by Venkatapathy et al. (13) they found a positive correla-
tion between serum and salivary creatinine levels in pa-
tients on dialysis and a negative correlation in controls. 
The increased serum creatinine levels in CKD patients 
create a concentration gradient that facilitates increased 
diffusion of creatinine from serum into saliva. So, a good 
positive correlation can be seen in CKD patients.
In the study by Martins et al. (8) on the Salivary analysis 
of patients with chronic renal failure undergoing hemo-
dialysis, a statistically significant difference was found 
between the salivary flow rate, concentrations of magne-
sium, phosphorus and potassium, whereas no significant 
difference was seen between salivary concentrations of 
sodium and calcium. They concluded that in patients 
with chronic renal failure, saliva composition is altered, 
and this may be reflected in the oral cavity. However, 
periodic hemodialysis seems to help control the flow and 
composition of saliva.
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Walt et al. (14) reported on a series of salivary markers 
that were associated with end stage renal disease. The 
list of markers included were Nitrite, Uric acid, sodium, 
chloride, pH, amylase and lactoferrin. Saliva levels of 
Nitrite and Uric acid consistently tracked dialysis, ex-
hibiting decreasing concentrations throughout the pro-
cess; the rate of decrease, however, varied by individual. 
The levels of Calcium, Magnesium, Phosphate and Po-
tassium were found to be statistically insignificant. In 
a subsequent study by Blicharz et al. (15) colorimetric 
test strips were used to monitor salivary nitrite and uric 
acid before and after hemodialysis. It was suggested that 
a salivary test could be used by patients to decide when 
dialysis is required, thereby eliminating unnecessary vi-
sits to a dialysis clinic.
In our study, we analyzed the flow rate, pH and the bio-
chemical components of saliva such as urea, creatinine, 
sodium, potassium, chloride and calcium before and af-
ter a hemodialysis session, so as to determine the effects 
of hemodialysis on the salivary composition and also to 
determine the biomarkers for monitoring the effective-
ness of hemodialysis. We found a statistically significant 
difference in the salivary flow rate and concentrations of 
urea, creatinine, chloride and potassium.
The present study did not consider the age related chan-
ges in salivary flow rate and composition. Total daily 
flow of whole saliva measures, on average, between 
500 mL and 1.5 L, depending on the reference. There 
are daily and annual ebbs and peaks in the salivary flow. 
Circadian (daily) low flow occurs during sleep, whereas 
peaks occur during high stimulation periods. Circannual 
(yearly) low flow occurs during the summer, whereas 
peak flow is during the winter. Circadian flow variations 
affect not only flow but also the concentration level of 
salivary components such as salivary electrolytes and 
proteins. Several factors may influence salivary flow and 
its composition. As a result, these vary greatly among 
individuals and in the same individual under different 
circumstances. Changes in the flow of saliva, pH values 
and biochemical composition are reflected on the oral 
clinical finding.
Further researches considering the above mentioned sa-
livary biomarkers may shed more light on the accuracy 
of the various salivary components in determining the 
effectiveness of dialysis and also on the effects of dialy-
sis on salivary composition and function.
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